Heim Health is a technology company.
Heim Health has raised $3.0M across 1 funding round.
Heim Health has raised $3.0M in total across 1 funding round.
Heim Health has raised $3.0M in total across 1 funding round.
Heim Health's investors include Firstminute Capital, Playfair Capital, Seaya Ventures, Jonathan Lenson, Mandeep Singh, Will Martin.
Heim Health is a technology company that provides an API-led digital platform designed to facilitate easy appointment booking and real-time availability for in-person clinical care delivered at patients' homes. It serves healthcare providers and patients by streamlining scheduling, care pathways, and clinical trial participation, making healthcare more accessible and convenient. The platform empowers practitioners with efficient scheduling tools and reduces administrative burdens, while patients benefit from flexible, personalized care plans and seamless booking experiences. Heim Health’s technology supports primary and secondary care, enhancing patient outcomes and provider income through improved operational efficiency[1][2][3].
Founded in 2022 in London, Heim Health (formerly known as Ally Health) was created to address the growing need for accessible, in-home clinical care. The company was established by a team of technologists, clinicians, and commercial experts, including CEO Kelly Klifa and Medical Director Dr. Elle Clarke. The idea emerged from recognizing that over 70% of patients require hands-on follow-up appointments, yet accessing such care remained cumbersome. Early traction came from partnerships with both private healthcare organizations and the NHS, enabling Heim Health to manage end-to-end delivery of at-home appointments and rapidly develop its platform with seed funding led by Heal Capital and other investors[1][3][4].
Heim Health rides the growing trend of digital health and home-based care, accelerated by increasing demand for convenient, patient-centered healthcare solutions. The timing is critical as healthcare systems worldwide seek to reduce hospital burdens and improve chronic disease management through remote and in-home services. Market forces such as aging populations, rising healthcare costs, and technological advancements in telehealth and data integration favor Heim Health’s model. By bridging the gap between patients and providers with seamless technology, Heim Health influences the broader ecosystem by enabling scalable, efficient home care delivery and supporting clinical trials outside traditional settings[1][2][3].
Looking ahead, Heim Health is poised to expand its platform capabilities and deepen partnerships with healthcare providers, including the NHS and private sectors. Trends such as personalized medicine, AI-driven care coordination, and increased patient empowerment will shape its journey. As the demand for home-based clinical services grows, Heim Health’s influence is likely to extend across more care pathways and geographies, potentially becoming a key enabler of decentralized healthcare. Continued investment in technology and operational support will be crucial to sustaining growth and impact in the evolving healthcare landscape[1][3][4].
Heim Health has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2024 | $3.0M Seed | Firstminute Capital, Playfair Capital, Seaya Ventures, Jonathan Lenson, Mandeep Singh, Will Martin |